Table 1.
Demographic and clinical characteristics of PLWH at enrollment into the University of Abuja Teaching Hospital HIV Treatment Program
| Characteristics | N = 5928 |
|---|---|
| Gender, n (%) | |
| Male | 36.1 |
| Female | 63.9 |
| Age, mean ± SD years | 34.5 ± 8.6 |
| Age, n (%) | |
| 15–24 years | 8.7 |
| 25–30 years | 23.0 |
| 30–34 years | 23.3 |
| 35–39 years | 19.6 |
| 40–44 years | 11.9 |
| 45–49 years | 7.4 |
| 50+ years | 6.0 |
| Service entry point, n (%) | |
| In-patient | 5.6 |
| Outside clinic/program | 22.1 |
| PMTCT | 1.7 |
| VCT | 66.2 |
| Other | 3.5 |
| ART regimen, n (%) | |
| D4T, 3TC, NVP | 17.7 |
| D4T, 3TC, EFV | 1.3 |
| AZT, 3TC, NVP | 40.8 |
| AZT, 3TC, EFV | 1.9 |
| TDF, XTC, NVP | 22.0 |
| TDF, XTC, EFV | 14.1 |
| Others | 2.1 |
| WHO stage, n (%) | |
| 1 | 39.7 |
| 2 | 24.4 |
| 3 | 32.0 |
| 4 | 3.9 |
| Weight, mean ± SD kg | 59.6 ± 17.5 |
| BMI, mean ± SD kg/m2 | 23.8 ± 7.0 |
| BMI, n (%) | |
| < 17 kg/m2 | 12.1 |
| 17–18.4 kg/m2 | 7.3 |
| 18.5–24.9 kg/m2 | 49.7 |
| 25–29.9 kg/m2 | 20.8 |
| 30+ kg/m2 | 10.1 |
| CD4 count, mean ± SD cells/mm3 | 268 ± 23.7 |
| CD4 Count, n (%) | |
| < 200 cells/µL | 52.2 |
| 200+ cells/µL | 88.2 |
| log10 viral load, mean ± SD copies/mL | 3.3 ± 1.3 |
PMTCT prevention of mother-to-child transmission, VCT voluntary counselling and testing, Mean ± SD mean and standard deviation, n(%) number and percentage, D4T Stavudine, 3TC Lamivudine, NVP nevirapine, EFV efavirenz, AZT zidovudine, TDF tenofovir, XTC emtricitabine, ART antiretroviral therapy, WHO World Health Organisation, BMI body mass index